Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$679,496,724
+$19,293,383 QoQ
Shares Held
2,675,500
-0.9% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#80
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $3,483,940,248 across 16 Drug Manufacturers - General names. JNJ ranks #2 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
781,929 | $937,869,169 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,675,500 | $679,496,724 | |
| 3 | ABBV |
AbbVie Inc.
|
1,621,115 | $407,937,369 | |
| 4 | AZN |
Astrazeneca PLC
|
2,033,587 | $385,608,756 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,578,024 | $331,276,081 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,215,423 | $242,892,664 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,070,731 | $135,276,147 | |
| 8 | PFE |
Pfizer Inc
|
5,482,863 | $132,027,333 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $679,496,724 | 2,675,500 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $660,203,341 | 2,700,881 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $557,245,974 | 2,692,660 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $510,189,049 | 2,751,532 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $376,283,577 | 2,463,395 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $431,843,036 | 2,603,974 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $352,649,061 | 2,438,453 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $369,428,729 | 2,279,580 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $302,308,128 | 2,068,337 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $329,467,211 | 2,082,731 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $283,323,845 | 1,807,604 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $296,908,868 | 1,906,317 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $386,945,035 | 2,337,754 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $374,054,060 | 2,413,252 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $391,410,288 | 2,215,739 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $370,864,767 | 2,270,230 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $469,076,023 | 2,642,533 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $518,790,838 | 2,927,218 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $510,522,140 | 2,984,288 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $504,386,943 | 3,123,139 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $442,534,137 | 2,686,258 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $493,297,670 | 3,001,507 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $439,374,265 | 2,791,805 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $377,103,951 | 2,532,939 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $395,513,572 | 2,812,441 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $450,443,737 | 3,435,093 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||